Comparison of inhaled salbutamol with placebo (water for inj.) on recovery process of newborns' transient tachypnea

Phase 3

• Conditions: Transient tachypnea of Newborns.; Transient tachypnoea of newborn; P22.1

• Registration Number: IRCT20190503043457N1
• Lead Sponsor: Vice chancellor for research and technology, Qom university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

A healthy term newborn with mild to moderate respiratory distress

Exclusion Criteria

Multiple anomalies
Severe infection
Metabolic disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of breaths. Timepoint: 30 minutes, one and four hours after treat. Method of measurement: By physician based on the number of breaths per minute.;Percent saturation of oxygen. Timepoint: 30 minutes, one and four hours after treat. Method of measurement: By pulse oximetry.;Heart rate. Timepoint: 30 minutes, one and four hours after treat. Method of measurement: By pulse oximetry.